AmCad BioMed Corporation

ADVANCED BREAKTHROUGHS IN MED-TECH ARE HELPING THE ISLAND ESTABLISH ITSELF AS A ONE-STOP DESTINATION FOR MEDICAL NEEDS.

AmCAD-UO® uses artificial intelligence (AI) and ultrasound technologies to detect OSA is truly smart and innovative being selected for this year's Taiwan Excellence Awards and CNBC News Project.

Taiwan Excellence Awards partner with CNBC news to drive awareness of 3 specially selected award-winning products from Taiwan and one of them is AmCAD-UO® using AI technology to detect OSA in about 10 minutes.  The partnership includes featuring AmCAD-UO® in CNBC’s digital publications and unique advertising on the NASDAQ billboard in Times Square of New York from September 28 to October 04, 2022. AmCAD-UO® will also be featured in taxi advertising in several big cities, along with other media opportunities across the USA.

According to the project host, AmCAD-UO® is characterized by reinventing shapes for the use of ultrasound and gives the ultrasound whole new types of clinical use. AmCAD-UO® incorporates an ultrasound machine and the latest AI deep learning algorithms set new standards and lay the foundations for industry change in OSA diagnosis.

Please click below links for more details
AmCad website news
CNBC website news